← Browse by Condition
Medical Condition

relapsed or refractory acute myeloid leukemia aml

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT02074839 Phase 1
Recruiting

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Enrollment
291 pts
Location
United States, Franc...
Sponsor
Institut de Recherches Interna...
View Trial →